TalkMed Group (SGX:5G3) Beginning Cash Position : S$81.07 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group Beginning Cash Position?

TalkMed Group's Beginning Cash Position for the quarter that ended in Dec. 2023 was S$81.07 Mil.

TalkMed Group's quarterly Beginning Cash Position declined from Dec. 2022 (S$83.75 Mil) to Jun. 2023 (S$80.59 Mil) but then increased from Jun. 2023 (S$80.59 Mil) to Dec. 2023 (S$81.07 Mil).

TalkMed Group's annual Beginning Cash Position increased from Dec. 2021 (S$79.43 Mil) to Dec. 2022 (S$82.16 Mil) but then declined from Dec. 2022 (S$82.16 Mil) to Dec. 2023 (S$80.59 Mil).

TalkMed Group Beginning Cash Position Historical Data

The historical data trend for TalkMed Group's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group Beginning Cash Position Chart

TalkMed Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

73.99

80.70

79.43

82.16

80.59

TalkMed Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															80.95	82.16	83.75	80.59	81.07

TalkMed Group Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

TalkMed Group Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of TalkMed Group's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

TalkMed Group (SGX:5G3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510

Website

https://www.talkmed.com.sg

TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group (SGX:5G3) Headlines

No Headlines